taurine and Neutropenia studies

taurine and Neutropenia

taurine has been researched along with Neutropenia in 2 studies

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research Excerpts

Excerpt	Relevance	Reference
" Patients with haematological cancer who are expected to develop prolonged neutropenia (> 7 days) and who have a non-tunnelled CVC implanted will be randomised to receive prophylactic taurolidine-citrate-heparin solution using a lock technique (study group) or heparin alone (placebo group)."	5.27	Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). ( Aguilar-Guisado, M; Arnan, M; Berbel, D; Carratalà, J; Cisneros-Herreros, JM; Encuentra, M; Gudiol, C; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Royo-Cebrecos, C, 2018)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

1 (50.00)

2.80

Authors

Authors	Studies
Gudiol, C	2
Arnan, M	2
Aguilar-Guisado, M	2
Royo-Cebrecos, C	2
Sánchez-Ortega, I	1
Montero, I	2
Martín-Gandul, C	2
Laporte-Amargós, J	1
Albasanz-Puig, A	1
Nicolae, S	2
Perayre, M	2
Berbel, D	2
Tebe, C	1
Riera, J	1
Sureda, A	1
Cisneros, JM	1
Carratalà, J	2
Encuentra, M	1
Cisneros-Herreros, JM	1

Studies

Gudiol, C

Arnan, M

Aguilar-Guisado, M

Royo-Cebrecos, C

Sánchez-Ortega, I

Montero, I

Martín-Gandul, C

Laporte-Amargós, J

Albasanz-Puig, A

Nicolae, S

Perayre, M

Berbel, D

Tebe, C

Riera, J

Sureda, A

Cisneros, JM

Carratalà, J

Encuentra, M

Cisneros-Herreros, JM

Trials

2 trials available for taurine and Neutropenia

Article	Year
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Do	2020
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). Trials, 2018, May-02, Volume: 19, Issue:1 Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central	2018

Article

Year

A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.

Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2

Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Do

2020

Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).

Trials, 2018, May-02, Volume: 19, Issue:1

Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central

2018